Filtered By:
Specialty: Internal Medicine
Source: European Journal of Internal Medicine
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 213 results found since Jan 2013.
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence.
CONCLUSIONS: Our findings suggest that DT is safer than TT with regard to occurrence of major bleeding. DT with a direct oral anticoagulant plus clopidogrel at discharge could be effective in most patients, maintaining aspirin in periprocedural phase and as longer "tailored" treatment for patients at higher ischemic risk.
PMID: 32063489 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - February 12, 2020 Category: Internal Medicine Authors: Ricottini E, Nenna A, Melfi R, Giannone S, Lusini M, Sciascio GD, Chello M, Ussia GP, Grigioni F Tags: Eur J Intern Med Source Type: research
Clinical outcomes and need for intensive care after non-ST-segment-elevation myocardial infarction.
CONCLUSIONS: Complications requiring ICU care were infrequent in a cohort of NSTEMI patients who were routinely admitted to the ICU over a 4-year period. The ACTION risk score had low accuracy in the prediction of complications requiring ICU care in our population.
PMID: 32089424 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - February 19, 2020 Category: Internal Medicine Authors: Guimarães PO, Sampaio MC, Malafaia FL, Lopes RD, Fanaroff AC, de Barros E Silva PGM, Dos Santos TM, Okada MY, Mouallem ARE, Diniz MDS, Custódio JV, Garcia JCT, Furlan V Tags: Eur J Intern Med Source Type: research
Abnormal ankle-brachial index (ABI) predicts primary and secondary cardiovascular risk and cancer mortality.
CONCLUSIONS: The co-existence of abnormal ABI and a history of CV events identifies subjects at higher risk, who call for a more aggressive approach. Abnormal ABI is also a predictor of cancer mortality.
PMID: 32151490 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - March 5, 2020 Category: Internal Medicine Authors: Visonà A, De Paoli A, Fedeli U, Tonello D, Zalunardo B, Zanatta N, Martini R, Pesavento R, Cuppini S, Prior M, Benazzi S, Cimminiello C, Avossa F Tags: Eur J Intern Med Source Type: research
Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura.
CONCLUSIONS: Our findings suggest that a careful comprehensive geriatric assessment of acquired TTP patients is necessary. It is important to look for other autoimmune diseases and such age-related comorbidities as osteoporosis, arterial hypertension, ischemic heart disease and cerebrovascular disease.
PMID: 32201091 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - March 18, 2020 Category: Internal Medicine Authors: Agosti P, Mancini I, Gianniello F, Bucciarelli P, Artoni A, Ferrari B, Pontiggia S, Trisolini SM, Facchini L, Carbone C, Peyvandi F, Italian Group of TTP Investigators Tags: Eur J Intern Med Source Type: research
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis.
CONCLUSIONS: ACEi/ARB and MRA can be safely used in CA, provided that no contraindications are present, treatment is started at a low dose and slowly up-titrated, and patients are monitored quite closely. Beta-blocker therapy is less tolerated in patients with AL amyloidosis and/or worse haemodynamic function.
PMID: 32475765 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - May 27, 2020 Category: Internal Medicine Authors: Aimo A, Vergaro G, Castiglione V, Rapezzi C, Emdin M Tags: Eur J Intern Med Source Type: research
Intermountain chronic disease risk score (ICHRON) validation for prediction of incident chronic disease diagnoses in an australian primary prevention population.
CONCLUSION: ICHRON predicted ChrD diagnosis at 3-years among an external, geographically distant validation cohort. These findings show the value of ICHRON for primary care patients in distinct locales. Additionally, electronic calculation of ICHRON empowers the clinical use of this tool to identify and differentially manage and treat high-risk patients.
PMID: 32563688 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - June 16, 2020 Category: Internal Medicine Authors: May HT, Anderson JL, Muhlestein JB, Knowlton KU, Horne BD Tags: Eur J Intern Med Source Type: research
The CHA2DS2-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?
CONCLUSIONS: The CHA2DS2-VASc score significantly correlated with neuro-cognitive performance, depressive symptoms and physical functioning. It was also associated with AF relapse. Accordingly, in the elderly, the CHA2DS2-VASc could help quantify thrombo-embolic risk, give an indication of frailty status and help to choose between a rate- and a rhythm-control strategy.
PMID: 32709545 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - July 21, 2020 Category: Internal Medicine Authors: Fumagalli S, Pelagalli G, Montorzi RF, Marozzi I, Migliorini M, D'Andria MF, Lip GYH, Marchionni N Tags: Eur J Intern Med Source Type: research
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
In conclusion, uric acid is emerging as a potentially treatable risk factor for cardiometabolic diseases, and more clinical trials investigating the potential benefit of lowering serum uric acid are recommended in individuals with hyperuricaemia with and without deposition and concomitant hypertension, metabolic syndrome or chronic kidney disease.
PMID: 32739239 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - July 28, 2020 Category: Internal Medicine Authors: Borghi C, Agabiti-Rosei E, Johnson RJ, Kielstein JT, Lurbe E, Mancia G, Redon J, Stack AG, Tsioufis KP Tags: Eur J Intern Med Source Type: research
Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation.
CONCLUSION: Over one-fourth of LVAD recipients have 30-day readmissions, with most of them occurring within 15 days. Most frequent cause of readmission was gastrointestinal bleeding, which was associated with the lowest in-hospital mortality among other complications.
PMID: 33039191 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - October 7, 2020 Category: Internal Medicine Authors: Briasoulis A, Ueyama H, Kuno T, Asleh R, Alvarez P, Malik AH Tags: Eur J Intern Med Source Type: research
Validation of the AF-ESUS score to identify patients with embolic stroke of undetermined source and low risk of device-detected atrial fibrillation
Eur J Intern Med. 2021 May 2:S0953-6205(21)00116-3. doi: 10.1016/j.ejim.2021.04.003. Online ahead of print.NO ABSTRACTPMID:33952425 | DOI:10.1016/j.ejim.2021.04.003
Source: European Journal of Internal Medicine - May 6, 2021 Category: Internal Medicine Authors: Alkisti Kitsiou Dimitrios Sagris Wolf-R üdiger Schäbitz George Ntaios Source Type: research
Refining age stratum of the C < sub > 2 < /sub > HEST score for predicting incident atrial fibrillation in a hospital-based Chinese population
CONCLUSION: In a hospital-based Chinese population, by refining the age strata of the original C2HEST score, the mC2HEST score had significantly increased predictive accuracy and discriminative capability for incident AF. The clinical benefits of the application of novel mC2HEST score needs further validation in multiple settings.PMID:33975769 | DOI:10.1016/j.ejim.2021.04.014
Source: European Journal of Internal Medicine - May 12, 2021 Category: Internal Medicine Authors: Yan-Guang Li Jin Bai Gongbu Zhou Juan Li Yi Wei Lijie Sun Lingyun Zu Shuwang Liu Source Type: research
